NO20084276L - Orodispergerbare domperidontabletter - Google Patents

Orodispergerbare domperidontabletter

Info

Publication number
NO20084276L
NO20084276L NO20084276A NO20084276A NO20084276L NO 20084276 L NO20084276 L NO 20084276L NO 20084276 A NO20084276 A NO 20084276A NO 20084276 A NO20084276 A NO 20084276A NO 20084276 L NO20084276 L NO 20084276L
Authority
NO
Norway
Prior art keywords
orodispersible
domperidone tablets
orodispersible domperidone
tablets
maltodextrin
Prior art date
Application number
NO20084276A
Other languages
English (en)
Inventor
Didier Berthoumieu
Jean-Francois Cordoliani
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of NO20084276L publication Critical patent/NO20084276L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse angår en orodispergerbar tablett som omfatter, regnet på vekt, maksimalt 15 % av et lavdose, terapeutisk aktivt stoff, fra 55-70 % mannitol med en partikkelstørrelse mellom 20 µm og 300 µm, minst 2 % av maltodekstrin, fra 3,5 % til 8 % krosskarmellosenatrium, fra 10 % til 20 % mikrokrystallinsk cellulose, fra 0,5 % til 1,5 % magnesiumstearat og fra 1,0 til 5 % smaksstoff(er) og søtningsstoff(er).
NO20084276A 2006-03-15 2008-10-13 Orodispergerbare domperidontabletter NO20084276L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0602253A FR2898492B1 (fr) 2006-03-15 2006-03-15 Comprimes orodispersibles de domperidone
PCT/EP2007/052388 WO2007104771A1 (en) 2006-03-15 2007-03-14 Orodispersible domperidone tablets

Publications (1)

Publication Number Publication Date
NO20084276L true NO20084276L (no) 2008-11-26

Family

ID=37580660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084276A NO20084276L (no) 2006-03-15 2008-10-13 Orodispergerbare domperidontabletter

Country Status (30)

Country Link
US (1) US8852633B2 (no)
EP (1) EP2007384B1 (no)
JP (1) JP5184383B2 (no)
KR (1) KR101468750B1 (no)
CN (1) CN101394850B (no)
AR (1) AR059852A1 (no)
AT (1) ATE435016T1 (no)
AU (1) AU2007224419B2 (no)
BR (1) BRPI0708880A2 (no)
CA (1) CA2645629C (no)
CY (1) CY1109405T1 (no)
DE (1) DE602007001465D1 (no)
DK (1) DK2007384T3 (no)
ES (1) ES2328532T3 (no)
FR (1) FR2898492B1 (no)
HK (1) HK1125848A1 (no)
IL (1) IL193878A (no)
MA (1) MA30378B1 (no)
MX (1) MX2008011835A (no)
NO (1) NO20084276L (no)
NZ (1) NZ571772A (no)
PL (1) PL2007384T3 (no)
PT (1) PT2007384E (no)
RU (1) RU2449793C2 (no)
SI (1) SI2007384T1 (no)
TN (1) TNSN08349A1 (no)
TW (1) TWI389708B (no)
UA (1) UA92077C2 (no)
WO (1) WO2007104771A1 (no)
ZA (1) ZA200808274B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2018153T3 (da) * 2006-04-26 2012-07-23 Rosemont Pharmaceuticals Ltd Flydende orale sammensætninger
FR2909877B1 (fr) * 2006-12-13 2009-07-10 Galenix Dev Soc Par Actions Si Composition pharmaceutique contenat de la 5-chloro-1-[1-[3- (2-oxo-2,3-dihydro-1h-benzimidazol-1-yl)propyl] piperidin-4-yl]-1,3-dihydro-2h-benzimidazol-2-one et son procede de preparation
JP2009114113A (ja) * 2007-11-06 2009-05-28 Nipro Corp 口腔内崩壊錠及びその製造方法
JP2010241760A (ja) * 2009-04-09 2010-10-28 Takada Seiyaku Kk 不快な味の軽減された口腔内速崩壊錠及びその製造方法
PT2238974E (pt) 2009-04-09 2013-07-09 E Pharma Trento Spa Granulado para a formulação de comprimidos orodispersíveis
KR20130009553A (ko) * 2011-07-15 2013-01-23 한미약품 주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제
CN104127390B (zh) * 2014-08-05 2016-05-11 孙丽华 一种多潘立酮片及其制备工艺
CN106236727B (zh) * 2016-08-30 2018-11-09 林州中农颖泰生物肽有限公司 一种安乃近泡腾片及其制备方法
MX2023003432A (es) * 2020-09-29 2023-08-04 Millicent Pharma Ltd Formulaciones orodispersables.
CN112656690A (zh) * 2021-01-29 2021-04-16 南京科技职业学院 一种适用于固体原料分散制粒的制药工艺方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
JP3797387B2 (ja) * 1996-06-14 2006-07-19 協和醗酵工業株式会社 口腔内速崩壊錠
KR100481583B1 (ko) * 1996-06-14 2005-07-12 교와 핫꼬 고교 가부시끼가이샤 구강내에서빠르게붕괴하는정제
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
EP1047407A4 (en) * 1997-12-19 2007-05-02 Smithkline Beecham Corp METHOD FOR PRODUCING A COUTINE TABLET
KR20010006835A (ko) 1999-03-25 2001-01-26 김선진 경구용 속붕해정
WO2000057857A1 (en) 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
EP1200090B1 (en) * 1999-08-03 2013-09-11 ICOS Corporation Pharmaceutical formulation comprising a beta-carboline and its use for treating sexual dysfunction
AR030630A1 (es) * 2000-09-11 2003-08-27 Novartis Ag Composiciones farmaceuticas
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation

Also Published As

Publication number Publication date
JP2009530244A (ja) 2009-08-27
PL2007384T3 (pl) 2009-12-31
AU2007224419B2 (en) 2012-12-20
RU2449793C2 (ru) 2012-05-10
MX2008011835A (es) 2008-09-29
CY1109405T1 (el) 2014-07-02
FR2898492A1 (fr) 2007-09-21
MA30378B1 (fr) 2009-05-04
CN101394850B (zh) 2013-05-29
DE602007001465D1 (de) 2009-08-13
KR101468750B1 (ko) 2014-12-03
ZA200808274B (en) 2009-08-26
PT2007384E (pt) 2009-08-25
ATE435016T1 (de) 2009-07-15
TNSN08349A1 (en) 2009-12-29
UA92077C2 (uk) 2010-09-27
AR059852A1 (es) 2008-04-30
NZ571772A (en) 2010-06-25
CN101394850A (zh) 2009-03-25
CA2645629A1 (en) 2007-09-20
WO2007104771A1 (en) 2007-09-20
ES2328532T3 (es) 2009-11-13
TWI389708B (zh) 2013-03-21
RU2008139969A (ru) 2010-04-20
AU2007224419A1 (en) 2007-09-20
HK1125848A1 (en) 2009-08-21
EP2007384A1 (en) 2008-12-31
US20090081288A1 (en) 2009-03-26
FR2898492B1 (fr) 2008-06-06
BRPI0708880A2 (pt) 2011-06-14
KR20080111473A (ko) 2008-12-23
IL193878A (en) 2011-02-28
TW200812644A (en) 2008-03-16
EP2007384B1 (en) 2009-07-01
SI2007384T1 (sl) 2009-12-31
US8852633B2 (en) 2014-10-07
JP5184383B2 (ja) 2013-04-17
DK2007384T3 (da) 2009-09-07
CA2645629C (en) 2014-04-29

Similar Documents

Publication Publication Date Title
NO20084276L (no) Orodispergerbare domperidontabletter
NO20045072L (no) Tablett med hoyt medikamentinnhold
NO20082265L (no) Dispergerbare tabletter som innbefatter deferasirox
NO20084065L (no) Hurtig frigivelses paracetamol tabletter
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
WO2008040534A3 (en) Non-mucoadhesive film dosage forms
NO20081889L (no) Fast vaksine formulering
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
NO20082156L (no) Preparat omfattende en kolesterolabsorpsjonsinhibitor, en HMG-CoA-reduktaseinhibitor og et stabiliserende middel
FI2498756T4 (fi) Neratinibimaleaatin tablettiformulaatiot
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
MXPA05002942A (es) Forma de dosificacion oral de liberacion modificada.
NO20083104L (no) Fast preparat
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
NO20080177L (no) 1-[(3-Hydroksyadamant-1-ylamino)acetyl]pyrrolidin-2(S)-karbonitrilformulering med modifisert frigivning
MX337603B (es) Composiciones y tabletas farmaceuticas con recubrimiento compresible y metodos de fabricacion.
MX343358B (es) Tabletas de acetato de ulipristal.
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
NO20090467L (no) Tablettformuleringer med umiddelbar frigivelse av en trombinreseptorantagonist.
TW200700062A (en) Pharmaceutical compositions
WO2008129517A3 (en) A stabilized delayed release pharmaceutical composition of rabeprazole
NO20080248L (no) Tablett inneholdende lite opploselig, aktiv bestanddel
EA201001108A1 (ru) Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
WO2006020522A3 (en) Multiplex drug delivery device
ZA200506992B (en) Fibrate tablet and method for the production thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application